Rapt cuts im­munol­o­gy pro­gram fol­low­ing clin­i­cal holds

Rapt Ther­a­peu­tics is of­fi­cial­ly shelv­ing its mid-stage im­munol­o­gy can­di­date af­ter a case of liv­er fail­ure trig­gered clin­i­cal holds ear­li­er this year.

Back in Feb­ru­ary, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER